Search Results - "Malec, V."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer by Sufliarsky, J, Chovanec, J, Svetlovska, D, Minarik, T, Packan, T, Kroslakova, D, Lalabova, R, Helpianska, L, Horvathova, D, Sevcik, L, Spacek, J, Laluha, A, Tkacova, V, Malec, V, Rakicka, G, Magdin, D, Jancokova, I, Dorr, A, Stresko, M, Habetinek, V, Koza, I

    Published in Neoplasma (2009)
    “…Despite progress in primary treatment of patients with advanced ovarian cancer, the majority develop recurrence of the disease. A platinum salt treatment,…”
    Get more information
    Journal Article
  2. 2
  3. 3

    Vinorelbine, Epirubicin, and Methotrexate (VEM) as Primary Treatment in Locally Advanced Breast Cancer by Abrahamova, J., Wagnerova, M., Kubala, E., Malec, V., Simova, E., Sirakova, I., Pavlikova, E., Machova, D., Kocak, I., Pavlikova, I., Tuma, P., Prausova, J., Kroslakova, D., Van Praagh, I.

    Published in The oncologist (Dayton, Ohio) (01-01-2001)
    “…Purpose. This phase II trial of VEM (vinorelbine + epirubicine + methotrexate) in the treatment of locally advanced breast cancer was conducted to obtain…”
    Get full text
    Journal Article
  4. 4

    Randomized, Double-Blind, Active-Controlled Trial of Every-3-Week Darbepoetin Alfa for the Treatment of Chemotherapy-Induced Anemia by Canon, Jean-Luc, Vansteenkiste, Johan, Bodoky, György, Mateos, M. Victoria, Bastit, Laurent, Ferreira, Irene, Rossi, Greg, Amado, Rafael G.

    “…Background: In the United States, darbepoetin alfa (Aranesp) is often used to treat patients with chemotherapy-induced anemia using weekly or every-2-week…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Inhibition of proliferation of HeLa cells by cocultivation with early mouse embryos (preliminary report) by MALEC, V, BABUSIK, P, KULISKOVA, L

    Published in Neoplasma (1990)
    “…Eight- to 16-cell zona-free mouse embryos were cocultivated with 5 to 10 HeLa cells in cultivation drops of 0.1 microliter containing D-PBS medium supplemented…”
    Get full text
    Journal Article